Global HLA (Human Leukocyte Antigen) Typing Market Insights Forecasts to 2032
- The Global HLA (Human leukocyte antigen) Typing Market Size was valued at USD 1.4 billion in 2022.
- The Global HLA (Human leukocyte antigen) Typing Market is growing at a CAGR of 5.8% from 2022 to 2032.
- The worldwide HLA (Human leukocyte antigen) Typing Market size is expected to reach USD 2.4 billion by 2032.
- Asia Pacific is expected to grow the fastest during the forecast period.
Get more details on this report -
The Global HLA (Human Leukocyte Antigen) Typing Market Size is expected to reach USD 2.4 billion by 2032, at a CAGR of 5.5% during the forecast period 2022 to 2032.
Human leukocyte antigen (HLA) testing assesses if patients and donors are compatible with cord blood or bone marrow donations. Human leukocyte antigens (HLA) are proteins found in human bodies. These markers are used by the human immune system to detect which cells are native to your body and which are alien. Also, HLA typing is useful for a variety of purposes, including ankylosing spondylitis diagnosis, paternity testing, kidney transplantation, and platelet transfusion. As a result, the market will expand more quickly. It can also tell you whether you have narcolepsy, rheumatoid arthritis, a stem cell transplant, or Behcet's disease. Furthermore, HLA matching is often utilized to determine tissue transplant compatibility. Every donor, whether organs from the deceased, family or others, is required to pass this test. As a result, a good match reduces the likelihood of problems following the transplant.
This research report categorizes the global HLA (Human leukocyte antigen) typing market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global HLA (Human leukocyte antigen) typing market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global HLA (Human leukocyte antigen) typing market. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market.
Global HLA (Human Leukocyte Antigen) Typing Market Report Coverage
|Market Size in 2022:||USD 1.4 Billion|
|Forecast Period 2022-2032 CAGR:||5.8%|
|2032 Value Projection:||USD 2.4 Billion|
|Historical Data for:||2018-2021|
|No. of Pages:||200|
|Tables, Charts & Figures:||130|
|Segments covered:||By Technique, ), By Product, By Application, By End User, By Region, and COVID-19 Impact Analysis|
|Companies Covered:||Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Omixon Inc., GenDx, Illumina Inc., TBG Diagnostics Limited, Dickinson and Company, Takara Bio Inc., F. Hoffman-La Roche Limited, and Pacific Biosciences And Other Key Venders|
|Pitfalls & Challenges:||COVID-19 has the potential to impact the global market|
Get more details on this report -
With the development of PCR-based genome sequencing and its integration with microfluidics, biomedical instruments, and robots, HLA-typing processes have shifted from serology-based to genome-based diagnostic approaches. In comparison to serological approaches, ongoing technical developments in HLA typing have resulted in better sample throughput, enhanced device sensitivity, early diagnosis of incompatibility, and improved procedural effectiveness. These benefits have raised the demand for HLA typing solutions among important end users such as research laboratories, hospitals, transplant centers, and diagnostic laboratories. Additionally, the growing need for organ transplants, as well as the widespread use of human leukocyte antigen (HLA) testing in pharmacogenetics, are projected to drive market growth. Other factors driving market expansion include technological improvements, an increase in the frequency of procedures involving stem cells, soft tissue, and solid organ transplantation, greater R&D assistance, and expanding public and private finance.
The high prices of NGS and PCR systems and equipment are too expensive. The high cost of these equipment and systems will exacerbate affordability difficulties, stifling industry expansion. The market's expansion is restricted by poor reimbursement regulations for organ transplants. Furthermore, the industry is experiencing a significant growth challenge due to the low number of donors compared to donor accepters.
- In 2022, the molecular assay segment is dominating the market with the largest market share during the forecast period.
On the basis of technique, the global HLA typing market is segmented into molecular assay, sequenced-based molecular assay, & non-molecular assay. Throughout these segments, the molecular assay segment is dominating the market with the largest revenue share during the forecast period. Molecular techniques such as massively parallel sequencing and probe-based hybridization approaches are the most commonly used in HLA typing. Molecular typing may be accomplished by a variety of genetic techniques, including PCR followed by massively parallel sequencing. The procedure used varies depending on the donors and organs to be transplanted. For example, molecular typing class I and II HLA loci are conducted for dead donors, whereas high-resolution molecular class typing I HLA loci are advised for hematopoietic stem cell transplantation.
- In 2022, the reagents and consumables segment is influencing the largest market share over the forecast period.
Based on the product, the global HLA typing market is bifurcated into different categories such as reagents & consumables, software & services. Among these segments, the reagents and consumables segment is dominating the market during the forecast period owing to the HLA reagents, and consumables are also utilized as supplemental items in a variety of diagnostic test kits, including HLA typing, to improve diagnostic accuracy and speed. According to Thermo Fisher Scientific Inc.'s annual report for 2021, the healthcare, clinical, and pharmaceutical industries are the primary users of reagents.
- In 2022, the diagnosis segment is dominating the market with the largest market share during the forecast period.
Based on the application, the global HLA typing market is segmented into diagnosis & research. Throughout these segments, the diagnosis segment is influencing the market with the largest revenue share over the forecast period. It can be used to diagnose diseases such as rheumatoid arthritis, narcolepsy, and Behcet's disease, paving the way for the market for HLA matching to accelerate. Recently, Mylab Discovery Solutions announced the launch of a detection kit, DiscoverSeries HLAB-27, for diagnosing Ankylosing Spondylitis in May 2022.
- In 2022, the hospitals and transplant centers segment is dominating the market with the largest market share over the forecast period.
On the basis of end user, the global HLA typing market is segmented into commercial service providers, hospitals and transplant centers, research labs & academic institutes. Among these segments, the diagnosis segment is dominating the market with the largest revenue share during the forecast period due to there being around 147 liver transplant hospitals and transplant centers in the United States. From January 2021 to December 2021, about 181 candidates in Houston Methodist Hospital got transplants from deceased donors and 1 from living donors. Similarly, 103 and 164 transplants were performed within the same period at Stanford Health Care and VCU Health System Authority, VCUMC, respectively. As a result of the increased number of transplants done in hospitals and transplant centers, the demand for HLA typing is increasing.
Regional Segment Analysis of the HLA (Human leukocyte antigen) typing market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America led the market with the largest market share of 46.94% during the forecast period
Get more details on this report -
North America is influencing significant market growth during the forecast period due to the presence of well-established academic institutions and research institutes in the region, together with the growing genetic illnesses, which is the primary predictor of the region's greatest market share. As a result, superior healthcare and research facilities are available. Furthermore, the government and businesses are focusing on breakthroughs in organ transplantation.
Asia Pacific is expected to experience high revenue market growth during the forecast period owing to improved healthcare infrastructure, well-designed reimbursement rules, and improved economic development, the industry has benefited. Along with improved access to skilled persons and transplant hospitals, laboratories outfitted with cutting-edge technology will propel the business ahead.
The report offers the appropriate analysis of the key organizations/companies involved within the global HLA (Human leukocyte antigen) typing market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Qiagen N.V.
- Omixon Inc.
- Illumina Inc.
- TBG Diagnostics Limited
- Dickinson and Company
- Takara Bio Inc.
- F. Hoffman-La Roche Limited
- Pacific Biosciences
Key Target Audience
- Market Players
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
- In March 2023, BioRad acquired AOAC International and AFNOR clearance for their iQ-Check kits, which are used in conjunction with the CFX Opus Deepwell Real-time PCR System.
- In May 2022, CareDx achieved CE certification for its AlloSeq HCT chimerism testing kit and AlloSeq HCT software. These AlloSeq are utilized in individuals who received hematopoietic cell transplantation.
This study forecasts revenue at global, regional, and country levels from 2022 to 2032. Spherical Insights has segmented the Global HLA Typing Market based on the below-mentioned segments:
Global HLA Typing Market, By Technique
- Molecular Assay
- Sequenced-based Molecular Assay
- Non-Molecular Assay
Global HLA Typing Market, By Product
- Reagents & Consumables
- Software & Services
Global HLA Typing Market, By Application
Global HLA Typing Market, By End User
- Commercial Service Providers
- Hospitals and Transplant Centers
- Research Labs & Academic Institutes
HLA Typing Market, By Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
Need help to buy this report?